GWA
CELG

Guidant Wealth Advisors’s Celgene Corp CELG Stock Holding History

Guidant Wealth Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25
Closed -$1K – 306
2018
Q4 		$1K Sell
25
-259
-91% -$19.1K ﹤0.01% 233
2018
Q3 		$25K Sell
284
-117
-29% -$10.3K 0.01% 111
2018
Q2 		$31K Sell
401
-401
-50% -$33.3K 0.01% 98
2018
Q1 		$69K Sell
802
-57
-7% -$5.47K 0.03% 67
2017
Q4 		$89K Hold
859
– – 0.04% 61
2017
Q3 		$119K Buy
+859
New +$117K 0.08% 48

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guidant Wealth Advisors's CELG Position: Q1 2019 in Review

Guidant Wealth Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 25 shares — an estimated $1K sold.

Guidant Wealth Advisors first reported a position in CELG in Q3 2017 and held it in 6 quarters. The position peaked at $119K in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Guidant Wealth Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Guidant Wealth Advisors sold 25 Celgene Corp shares in Q1 2019, an estimated $1K.
  • Guidant Wealth Advisors first reported a position in Celgene Corp in Q3 2017 and held it in 6 quarters.
  • Guidant Wealth Advisors's Celgene Corp position peaked at $119K in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Guidant Wealth Advisors's 13F filing for Q1 2019, filed 18 Apr 2019.